Walgreens 2013 Annual Report Download - page 33

Consolidated Balance Sheets
Walgreen Co. and Subsidiaries at August 31, 2013 and 2012 (In millions, except shares and per share amounts)
Assets 2013 2012
Current Assets Cash and cash equivalents $ 2,106 $ 1,297
Accounts receivable, net 2,632 2,167
Inventories 6,852 7,036
Other current assets 284 260
Total Current Assets 11,874 10,760
Non-Current Assets Property and equipment, at cost,
less accumulated depreciation and amortization 12,138 12,038
Equity investment in Alliance Boots 6,261 6,140
Alliance Boots call option 839 866
Goodwill 2,410 2,161
Other non-current assets 1,959 1,497
Total Non-Current Assets 23,607 22,702
Total Assets $ 35,481 $ 33,462
Liabilities and Shareholders’ Equity
Current Liabilities Short-term borrowings $ 570 $ 1,319
Trade accounts payable 4,635 4,384
Accrued expenses and other liabilities 3,577 3,019
Income taxes 101 —
Total Current Liabilities 8,883 8,722
Non-Current Liabilities Long-term debt 4,477 4,073
Deferred income taxes 600 545
Other non-current liabilities 2,067 1,886
Total Non-Current Liabilities 7,144 6,504
Commitments and Contingencies (see Note 12)
Shareholders’ Equity Preferred stock, $.0625 par value;
authorized 32 million shares; none issued — —
Common stock, $.078125 par value; authorized 3.2 billion shares;
issued and outstanding 1,028,180,150 shares in 2013 and 2012 80 80
Paid-in capital 1,074 936
Employee stock loan receivable (11) (19)
Retained earnings 21,523 20,156
Accumulated other comprehensive (loss) income (98) 68
Treasury stock at cost, 81,584,572 shares in 2013
and 84,124,816 shares in 2012 (3,114) (2,985)
Total Shareholders’ Equity 19,454 18,236
Total Liabilities and Shareholders’ Equity $ 35,481 $ 33,462
The accompanying Notes to Consolidated Financial Statements are integral parts of these statements.
2013 Walgreens Annual Report 31